Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JPM vs GSK✓SelectedUSD · GSKJPM vs GSK performance historyLatest closeAs of-3.03%11/20
Stock and ETF performance explorer

JPM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+113.9%
GSK return
+40.7%
Excess return
+73.2%
Maximum drawdown
-37.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.0%-0.1%-2.9%-3.0%
7D-10.3%-5.3%-5.0%-9.5%
30D-7.4%-3.7%-3.7%-6.8%
3M-11.2%-7.3%-4.0%-10.2%
6M+3.8%-4.2%+8.1%+4.3%
YTD-1.8%+0.9%-2.6%-2.2%
1Y+6.1%+7.3%-1.2%+4.7%
3Y+115.9%+52.7%+63.1%+95.3%
All+113.9%+40.7%+73.2%+79.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling